Functionally, NEDD4-1 knockdown results in enhanced cell viability and bortezomib resistance in MM cells, while NEDD4-1 overexpression mediates bortezomib sensitivity through regulation of MM cell apoptosis and cell cycle. This evidence concerns the gene NEDD4 and Miyoshi myopathy.